FREEX
Price
$19.80
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
VGSNX
Price
$21.53
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

FREEX vs VGSNX

Header iconFREEX vs VGSNX Comparison
Open Charts FREEX vs VGSNXBanner chart's image
Franklin Real Estate Securities A
Price$19.80
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.53
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FREEX vs VGSNX Comparison Chart
Loading...
VS
FREEX vs. VGSNX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FREEX is a StrongBuy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. FREEX (297M). VGSNX pays higher dividends than FREEX: VGSNX (4.01) vs FREEX (2.00). FREEX was incepted earlier than VGSNX: FREEX (31 years) vs VGSNX (21 years). FREEX is a more actively managed with annual turnover of: 10.69 vs. VGSNX (9.00). FREEX has a lower initial minimum investment than VGSNX: FREEX (1000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.90 vs. FREEX (19.48). VGSNX return over 5 years is better than : 26.84 vs. FREEX (-9.40).
FREEXVGSNXFREEX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years21 years-
Gain YTD11.58913.45286%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets297M70.5B0%
Annual Yield % from dividends2.004.0150%
Returns for 1 year19.4826.9072%
Returns for 3 years-7.933.64-218%
Returns for 5 years-9.4026.84-35%
Returns for 10 years19.7087.2923%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics